Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05012007 · ClinicalTrials.gov registry record · NA
Reminder Modality for CRC Screening
A NA study of Colorectal Cancer, sponsored by VA Puget Sound Health Care System.
- Completed
- Registry status
- NA
- Development phase
- 2,653
- Enrollment target
- 1
- Study location
NCT05012007: Completed NA study of Colorectal Cancer, sponsored by VA Puget Sound Health Care System.
NCT05012007 is a NA study of Colorectal Cancer that has completed, run by VA Puget Sound Health Care System. The registered enrollment target is 2,653 participants, above the 1,538-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (72% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05012007, a NA study of Colorectal Cancer, has completed, sponsored by VA Puget Sound Health Care System.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,653 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled trial that will evaluate the effectiveness of different reminder modalities for a population-based mailed FIT program at the VA Puget Sound among average risk Veterans who are due for annual colorectal cancer (CRC) screening.
Primary Outcome
the return rate at three months post randomization
Conditions Studied
Interventions
- OTHER Reminder Phone
- OTHER Reminder Text
Study Locations (1)
Washington
- VA Puget Sound Health Care System - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,653 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2022-04-26 |
| Phase | NA |
What the finished NCT05012007 record still lists
NCT05012007 is an interventional study that assigns participants to a tested intervention. Its 2,653 participants enrollment target places it among the larger protocols in the corpus, above the 1,538-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (72% higher).
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Reminder Phone is the first listed.
NCT05012007 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05012007 about?
NCT05012007 is a clinical study titled "Reminder Modality for CRC Screening". This is a randomized controlled trial that will evaluate the effectiveness of different reminder modalities for a population-based mailed FIT program at the VA Puget Sound among average risk Veterans who are due for annual colorectal cancer (CRC) screening.
What is the current status of trial NCT05012007?
This trial is currently completed. It is a NA study. The enrollment target is 2,653 participants. The study started on 2021-08-01. Estimated completion is 2022-04-26.
What conditions does trial NCT05012007 study?
This clinical trial studies the following conditions: Colorectal Cancer.
What interventions are being tested in trial NCT05012007?
The interventions under investigation include: Reminder Phone (OTHER), Reminder Text (OTHER).
Who is sponsoring clinical trial NCT05012007?
This trial is sponsored by VA Puget Sound Health Care System, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05012007 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05012007's enrollment target sits among peer trials
2,653 24th of 381 higher than 358 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06825715 · 2,653 participants · NA
Multilevel Intervention for Precision Oncology
- NCT06455085 · 2,634 participants · NA
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
- NCT05471908 · 2,674 participants · NA
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
- NCT05111925 · 2,690 participants
Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI